Metastatic Renal Cell Cancer Registry
The purpose of this study is to understand the treatment of patients with metastatic renal cell cancer in the US. The study will also explore patient experience through collection of patient reported outcomes.
Who can join?
Eligible participants may include those with:
- Metastatic renal cell cancer who have not been treated with chemotherapy
What is involved?
- Study commitment for up to 5 years
- Quality of Life Questionnaires